By Dan Prochilo ( January 6, 2014, 4:12 PM EST) -- Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. were hit Monday with another proposed antitrust class action, this in Minnesota federal court, over an alleged pay-for-delay deal that kept a generic form of an anti-stroke medication off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.